Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 122 pembrolizumab 118 Magnetic Resonance Spectroscopy 107 Carboplatin 86 Cyclophosphamide 75 Biopsy 68 Cisplatin 63 Paclitaxel 58 Bevacizumab 56 Gemcitabine 49 Nivolumab 47 fludarabine 44 Dexamethasone 39 Rituximab 38 Pemetrexed 38 Fluorouracil 37 atezolizumab 36 Docetaxel 36 Doxorubicin 34 Radiotherapy 33 Leucovorin 33 venetoclax 31 Oxaliplatin 30 Capecitabine 30 Temozolomide 28 Prednisone 28 Standard of Care 27 Radiation 27 Letrozole 27 Cetuximab 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Conservative Treatment × 30 days × Clear all

NCT06022159 2026-06-02

HYPOSARC

Institut Claudius Regaud

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡